Precision medicine

Also: Precision oncology platform OncoHost scores $35 million, home care startup Reverence emerges from stealth with $9.5 million and pediatric behavioral health startup Handspring Health completes a $6.2 million seed round.

Also: Imagene AI raises $21.5 million across two rounds for precision cancer care, and Capable Health scores $6 million in seed funding to help providers build healthcare apps.

Also: Rupa Health raised $20 million for its lab test platform, and CancerIQ scooped up $14 million in Series B funding.

The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.

The industrial giant plans to retain a stake of almost 20% in GE Healthcare.

The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.

IntelliSite is designed to streamline workflows, enhance diagnostic confidence, facilitate collaboration, integrate AI and increase the efficiency of pathology labs.

The SoftVue system is intended to be used in addition to digital mammograms to screen for cancer among patients with dense breast tissue.

The ANT-X system helps clinicians perform safe and accurate percutaneous needle placement.

Paige Prostate analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further.